55 reports

  • ANTIPSYCHOTIC DRUGS MARKET IN APAC
  • ANTIPSYCHOTICS WITH NOVEL MOA

About Antipsychotic Drugs Antipsychotic drugs are also called as major tranquilizers or neuroleptics. These drugs are primarily used for the treatment of psychiatric disorders such as schizophrenia, hallucinations, delusions, bipolar disorder, and others. The antipsychotic drugs market is expected to grow due to the rising number...

  • Antipsychotic
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • GlaxoSmithKline plc
  • Johnson & Johnson

Global Antipsychotic Drugs Market Analysis & Trends - Industry Forecast to 2025 ## Market Outline ##. ## Research Methodology ##. ##. ## Research Approach & Sources ##. ## Market Trends ##. ## Regulatory Factors ##. ## Application Analysis ##. ## Strategic Benchmarking ##. ## Opportunity Analysis

  • Antipsychotic
  • Therapy
  • United States
  • World
  • Forecast
  • FIRST-GENERATION ANTIPSYCHOTIC DRUGS
  • Second-generation antipsychotic drugs

About Schizophrenia Therapeutics Schizophrenia is a chronic mental disorder that alters the perception, thinking, and social behavior of an individual. Individuals suffering from this disease face difficulty in distinguishing between imaginary things and reality. Although schizophrenia is not as prevalent as other mental disorders,...

  • Antipsychotic
  • World
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • GlaxoSmithKline plc

Global Market Study on Schizophrenia Treatment: Use of Phenothiazine Antipsychotics to Increase in the Near Future ##.

  • Antipsychotic
  • Eastern Europe
  • Latin America
  • Western Europe
  • Market Size
  • 2.2 Anti-psychotic: An Overview
  • Anti-psychotic Patent Expiry Dates

Scope of the Report The report entitled “Global Long Acting Injectable Anti-psychotic Market: Size, Trends & Forecasts (2017-2021)”, provides analysis of the global injectable anti-psychotic market, with detailed analysis of market size and growth, and segmentation of the industry. The report also includes a detailed regional...

  • Antipsychotic
  • World
  • Market Size
  • Johnson & Johnson
  • Lundbeck Inc.

The second-generation segment of drugs accounted for the largest share in 2015 and are anticipated to further expand during the forecast period despite the adverse effects As of January 2016, the third-generation segment has only one approved product, Abilify.

  • Antipsychotic
  • Therapy
  • United States
  • Forecast
  • ANTIPSYCHOTICS
  • 45.24% of the market share comes from antipsychotics

About Bipolar Disorder Therapeutic Bipolar disorder, also called manic-depressive disorder, is a mental disorder that causes unusual mood swings in patients. The disease causes periods of depression and mania in patients. Technavio’s analysts forecast the global bipolar disorder therapeutic market to grow at a CAGR of...

  • Antipsychotic
  • Forecast
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Eli Lilly & Co.
  • GLOBAL ANTI-PSYCHOTICS MARKET COMPARISON BY PRODUCT PROFILE (2015)
  • 2.6 GLOBAL ANTI-PSYCHOTIC DRUG MARKET BY VALUE

Depression is a serious mood disorder, affecting the ability to think, feel, and handle situations like sleeping, eating, or working. It is a mood disorder that causes a persistent feeling of sadness and loss of interest. It builds up a very negative perspective in the way of thinking in every single thing and damages a person’s ability to...

  • Antipsychotic
  • World
  • AstraZeneca PLC
  • Lundbeck Inc.
  • Pfizer Inc.

MARKET ##.

  • Antipsychotic
  • APAC
  • Europe
  • United States
  • World
  • Antipsychotics Export Volume and Market Share (Billion
  • Antipsychotics Import Volume and Market Share (Billion

This study focuses on China’s Central Nervous System Disorder Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the...

  • Antipsychotic
  • China
  • Trade
  • AstraZeneca China Inc.
  • Beijing Sihuan Pharmaceutical Co., Ltd.
  • Antipsychotics Producer
  • Antipsychotics Export Volume and Market Share (Billion

China’s demand for Central Nervous System Disorder Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports,...

  • Antipsychotic
  • China
  • Demand
  • Market Size
  • Trade
  • 6.2.4 ATYPICAL ANTIPSYCHOTICS
  • 6.2.3 TYPICAL ANTIPSYCHOTICS

PharmaPoint: Bipolar Disorder - Global Drug Forecast and Market Analysis to 2024 Summary Bipolar disorder is a mental disorder characterized by periods of mania and depression. The frequency, severity, and pattern of these episodes can vary considerably over time and between individuals, making bipolar disorder one of...

  • Antipsychotic
  • World
  • Market Size
  • AstraZeneca PLC
  • Otsuka Pharmaceutical Co., Ltd.
  • 2.2 Antipsychotics Overview
  • Side Effects of Antipsychotics

Scope of the Report The report entitled “US Tardive Dyskinesia Market: Size, Trends & Forecasts (2016-2025)”, provides analysis of the US tardive dyskinesia market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The report also provides the analysis of the major...

  • Antipsychotic
  • United States
  • Market Size
  • Teva Pharmaceutical Industries Ltd.
  • Valeant Pharmaceuticals International, Inc.
  • 5.2.3 Typical Antipsychotics
  • 5.2.4 Atypical Antipsychotics

Bipolar Disorder - US Drug Forecast and Market Analysis to 2024 Summary Bipolar disorder is a mental disorder characterized by periods of mania and depression. The frequency, severity, and pattern of these episodes can vary considerably over time and between individuals, making bipolar disorder one of the most challenging...

  • Antipsychotic
  • World
  • Forecast
  • Eli Lilly & Co.
  • Otsuka Pharmaceutical Co., Ltd.
  • 5.2.3 Typical Antipsychotics
  • 5.2.4 Atypical Antipsychotics

Bipolar Disorder - Canada Drug Forecast and Market Analysis to 2024 Summary Bipolar disorder is a mental disorder characterized by periods of mania and depression. The frequency, severity, and pattern of these episodes can vary considerably over time and between individuals, making bipolar disorder one of the most challenging...

  • Antipsychotic
  • World
  • Forecast
  • Eli Lilly & Co.
  • Otsuka Pharmaceutical Co., Ltd.
  • 5.2.3 Typical Antipsychotics
  • 5.2.4 Atypical Antipsychotics

Bipolar Disorder - Japan Drug Forecast and Market Analysis to 2024 Summary Bipolar disorder is a mental disorder characterized by periods of mania and depression. The frequency, severity, and pattern of these episodes can vary considerably over time and between individuals, making bipolar disorder one of the most challenging...

  • Antipsychotic
  • World
  • Forecast
  • Eli Lilly & Co.
  • Otsuka Pharmaceutical Co., Ltd.
  • TYPICAL ANTIPSYCHOTICS SWOT ANALYSIS, 2016
  • TYPICAL ANTIPSYCHOTICS (EXCLUDING ADASUVE) ASSUMPTIONS

PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorder is characterized by several symptom domains including positive symptoms (such as hallucinations or delusions and...

  • Antipsychotic
  • Alkermes plc
  • Janssen Biotech, Inc.
  • Lundbeck Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • ALZHEIMER'S DISEASE DRUG DEVELOPMENT - AGENTS CURRENTLY IN PHASE I OF DEVELOPMENT, (AS OF MAY 2017)

India ##.

  • Antipsychotic
  • World
  • Biogen Idec Inc.
  • Eisai Co., Ltd.
  • Roche Group

Anti-Psychotic Drug Market by Value (2010-2015) Global Anti-Psychotic Drug Market Forecast by Value (2016-2020) The US Depressive Disorder Market Forecast by Value (2015-2020) The US Mental Health Drug Prescription by Volume (2011-2015) The US Depressive Disorder Patient Prevalence

  • Antipsychotic
  • Depression
  • Therapy
  • World
  • Forecast

Schizophrenia

4546 5000 3864
  • DESPITE THE NUMEROUS APPROVED ANTIPSYCHOTICS, BETTER-TOLERATED DRUGS ARE STILL NEEDED
  • THE ANTIPSYCHOTIC PATENT CLIFF WILL CREATE ROOM FOR NEW LEADING BRANDS

Schizophrenia’s unmet needs can be turned into key commercial opportunities to drive the growth of the market. This report addresses the following questions: - What will be the key growth drivers of the schizophrenia market? - Which will be the new leading brands in schizophrenia, now that former market-leader Abilify...

  • Antipsychotic
  • European Union
  • Japan
  • United States
  • Alkermes plc
  • PROVIDES A SWOT ANALYSIS OF ALLERGAN IN THE BIPOLAR DISORDER MARKET.
  • ALLERGAN SWOT ANALYSIS IN BIPOLAR DISORDER, 2014-2024

Bipolar Disorder - Current and Future Players Summary GlobalData has released its pharma report, “Bipolar Disorder - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Bipolar Disorder Market. The report identifies and analyses...

  • Antipsychotic
  • Allergan plc
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Janssen Biotech, Inc.
  • NMDA-R ANTAGONISTS
  • ANTICONVULSANT/MOOD STABILIZER

PharmaPoint: Alzheimer’s Disease - Global Drug Forecast and Market Analysis to 2026 Summary Alzheimer’s disease (AD) is a looming endangerment to global health, and a threat to the world economy. One in every three seniors in the US dies with AD or another form of dementia. It is the sixth leading...

  • Antipsychotic
  • Allergan plc
  • Biogen Idec Inc.
  • Eisai Co., Ltd.
  • Novartis AG

(Australia) ##.

  • Antipsychotic
  • Specialty Hospital
  • United States
  • Market Competition
  • Market Shares
  • Olanzapine Sales Volume (million yuan)
  • Mental Illness Drugs Industry Structure

Some of the traditional antipsychotic treatment is invalid or bad effects of the patients, it will be effective using this product.

  • Antipsychotic
  • China
  • Demand
  • Zhejiang Expressway Co., Ltd.
  • Zhejiang Jiuzhou Pharmaceutical Co Ltd
  • Clozapine
  • Olanzapine Sales Volume (million yuan)

This study focuses on China’s Mental Illness Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers...

  • Antipsychotic
  • Pharmaceutical
  • China
  • Demand
  • Zhejiang Jiuzhou Pharmaceutical Co Ltd

(USA) ##.

  • Antipsychotic
  • Hepatitis
  • Neurological Disorder
  • Pharmaceutical
  • Market Shares
  • Mental Illness Drugs Industry Structure

Scope of Business: ##.

  • Antipsychotic
  • China
  • Shandong JinTai Group Co., Ltd.
  • Zhejiang Expressway Co., Ltd.
  • Zhejiang Jiuzhou Pharmaceutical Co Ltd
  • May 01, 2017: Alkermes Announces Completion of Patient Enrollment in Pivotal Antipsychotic Efficacy Study of ALKS 3831 for Schizophrenia
  • May 01, 2017: Alkermes Announces Completion of Patient Enrollment in Pivotal Antipsychotic Efficacy Study of ALKS 3831 for Schizophrenia

Summary Alkermes Plc (Alkermes) is a biopharmaceutical company that focuses on the research, development and commercialization of drugs for the treatment of central nervous system (CNS) diseases. The company’s proprietary products include Aristada, an extended-release intramuscular injectable suspension for the treatment...

  • Antipsychotic
  • Pharmaceutical
  • United States
  • Company Financials
  • Alkermes plc
  • Jan 19, 2018: Otsuka Receives Approval in Japan for the Manufacture and Sale of New Antipsychotic Drug Rexulti Tablets for Schizophrenia
  • Feb 01, 2018: Sumitomo Dainippon Pharma Announces an Atypical Antipsychotic LONASEN is Now Available in China

Schizophrenia - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia - Pipeline Review, H1 2018, provides an overview of the Schizophrenia (Central Nervous System) pipeline landscape. Schizophrenia is a chronic,...

  • Antipsychotic
  • Mental Health
  • United States
  • Company
  • Omeros Corporation
  • MAY 19, 2017: KARUNA PHARMACEUTICALS TO PRESENT KARXT TOLERABILITY PROOF-OF-CONCEPT DATA FOR KARXT, A NOVEL ANTIPSYCHOTIC AGENT TARGETING THE MUSCARINIC RECEPTORS, AT TWO UPCOMING MEDICAL MEETINGS
  • VLP THERAPEUTICS LLC

Schizophrenia - Pipeline Review, H2 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia - Pipeline Review, H2 2017, provides an overview of the Schizophrenia (Central Nervous System) pipeline landscape. Schizophrenia is a chronic, severe, and disabling...

  • Antipsychotic
  • United States
  • Company
  • Product Initiative
  • Omeros Corporation